HEALTH● LOW1d ago · Sep 22, 2026, 10:52 AM
Roche GLP-1 delivers 16% weight loss in mid-stage trial
Seeking Alpha Tech · global
A mid-stage trial of Roche GLP-1 has shown that the drug delivers 16% weight loss. This indicates a promising development in pharmaceutical weight management.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.